In fact, genetic depletion of JNK3 in transgenic AD mice resulted in a dramatic reduction in Aβ42 peptide levels and overall plaque loads as well as in an increased number of neurons and improved cognition (Yoon et al., 2012). The gene discussed is MAPK10; the disease is Alzheimer disease.